期刊文献+

BRCA2基因启动子的克隆和分析 被引量:3

Cloning and analysis of the BRCA2 promoter
下载PDF
导出
摘要 目的构建BRCA2基因启动子的荧光素酶报告质粒,为BRCA2基因调控研究提供基础。方法采用高保真Taq聚合酶,从正常人外周血中扩增出BRCA2启动子并将其插入质粒中。通过基于PCR的定点突变方法在多态性位点rs3092989(-254A/G)获得含-254G等位基因的序列。亚克隆BRCA2启动子片段至pGL3-basic报告基因载体中,构建含BRCA2启动子的重组报告质粒。转染HeLa细胞,评价启动子活性以及-254A/G多态性位点对活性的影响。结果酶切和直接测序法证实所构建质粒含有pGL3-basic及BRCA2基因启动子序列,扩增的含-254A和-254G的BRCA2启动子序列正确。构建的报告基因具有启动子活性,与pGL3-basic质粒相比较,BRCA2启动子的相对荧光单位增加了413倍。rs3092989(-254A/G)多态位点未明显影响启动子活性。结论 BRCA2转录起始位点上游序列具有较强的启动子活性。成功克隆BRCA2启动子并引入相关突变,可为后续的基因转录调控研究奠定基础。 Purpose To construct the BRCA2 promoter luciferase reporter gene vector and analyze the mechanism of gene regulation. Methods By using genomic DNA from healthy people as template, the BRCA2 promoter region was amplified by high fidelity DNA polymerase. Then the fragment was cloned into a recombinant plasmid. To analyze whether polymorphism rs3092989 (-254A/G) could affect promoter activity, PCR-based mutagenesis was performed to generate haplotype containing -254G allele. After confirmed by direct sequencing, the BRCA2 promoter was subeloned into pGL3-basie vector. The constructed vector was transfected into HeLa cells to detect promoter activity. Results Direct sequencing and restriction endonuelease analysis confirmed the recombinant plasmid contained pGL3-basic vector and BRCA2 promoter sequence. The BRCA2 promoter containing -254A and -254G allele was success- fully cloned. The BRCA2 promoter exhibited strong promoter activity with an increase of 413 fold of relative luciferase activity unit (RLU) as compared with pGL3-basie vector. The -254A/G polymorphism did not affect promoter activity. Conclusion The cloned BRCA2 promoter region has strong promoter activity. The success of cloning and mutagenesis of BRCA2 promoter region could be used for further analysis of gene regulation.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2013年第2期138-140,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(31100944) 江苏省自然科学基金(BK2009107) 江苏省高校自然科学基金(09KJB320017)
关键词 BRCA2基因 启动子 克隆 基因调控 BRCA2 gene promoter cloning gene regulation
  • 相关文献

参考文献10

  • 1Duncan J A, Reeves J R, Cooke T G. BRCAI and BRCA2 pro- teins: roles in health and disease[ J ]. Mol Pathol, 1998,51(5 ): 237 - 47.
  • 2Kerr P, Ashworth A. New complexities for BRCAI and BRCA2 [J]. CurrBiol, 2001,11(16):R668-76.
  • 3Schubert E L, Lee M K, Mefford H C, et al. BRCA2 in American families with four or more cases of breast or ovarian caneer: recur- rent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCAI orBRCA2[J]. AmJ HumGenet, 1997,60(5) :1031 - 40.
  • 4Chan K Y, Liu W, Long J R, et al. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women[ J ]. J Med Genet, 2009,46( 1 ) :32 -9.
  • 5毛海婷,王雄彪,张玲,顾洪涛.CTLA-4在重症肌无力患者中的表达及其多态性导致的无效转录研究[J].中华微生物学和免疫学杂志,2005,25(4):257-262. 被引量:6
  • 6杨举伦,史爱学,邹红,李涛,杨海捷,蔡琳.乳腺癌发生过程中p53、BRCA1、BRCA2、PTEN、Rb蛋白异常表达[J].临床与实验病理学杂志,2005,21(3):277-281. 被引量:9
  • 7Egawa C, Miyoshi Y, Taguchi T, et al. High BRCA2 mRNA ex- pression predicts poor prognosis in breast cancer patients[ J ]. Int J Cancer, 2002,98 ( 6 ) :879 - 82.
  • 8Egawa C, Miyoshi Y, Takamura Y, et al. Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer[J]. Int J Cancer, 2001,95(4) :255 -9.
  • 9Bieche I, Nogues C, Lidereau R. Overexpression of BRCA2 gene in sporadic breast tumours [ J ]. Oncogene, 1999,18 ( 37 ) :5232 - 8.
  • 10Halsall J A, Osborne J E, Epstein M P, et al. The unfavorable effect of the A allele of the vitamin D receptor promoter polymor- phism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma [ J ]. Dermatoendocrinol, 2009,1(1) :54 -7.

二级参考文献42

  • 1RosaiJ 著 回允中 主译.阿克曼外科病理学[M](第8版)[M].沈阳:辽宁教育出版社,1999.2064.
  • 2Oaks MK, Hallett KM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol, 2000, 164: 5015-5018.
  • 3Magistrelli GP, Jeannin N, Herbault A, et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol, 1999, 29: 3596-3602.
  • 4Oaks MK, Hallett KM, Penwell RT, et al. A native soluble form of CTLA-4. Cell Immunol, 2000, 201: 144-153.
  • 5Masteller EL, Chuang E, Mullen AC, et al. Structural analysis of CTLA-4 function in vivo. J Immunol, 2000, 164: 5319-5327.
  • 6Ueda H, Howson JM, Esposito L, et al. Association of the T cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature, 2003, 423: 506-511.
  • 7Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun, 2001, 2: 145-152.
  • 8Anjos S, Nguyen A, Ounissi-Benkalha H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem, 2002, 277: 46478-46486.
  • 9Seidman JG, Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J Clin Invest, 2002, 109: 451-455.
  • 10Walunas TL, Lenschow DJ, Bakker CY. CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1994, 1: 405-413.

共引文献13

同被引文献20

  • 1聂传朋.关于内含子功能的简述[J].阜阳师范学院学报(自然科学版),2001,18(3):72-73. 被引量:1
  • 2王玉林,赵荣宇,张丽芝,关宏伟.BRCA1和BRCA2在乳腺疾病中的表达和意义[J].医师进修杂志(外科版),2005,28(5):13-15. 被引量:11
  • 3Hemmings S M, Martin I, I, Klopper M, et al. BDNF Va166Met and DRD2 TaqlA polymorphisms interact to in fluence PTSD symptom severity: A preliminary investiga- tion in a South Afriean population[ J ]. Prog Neuropsycho- pharmacol Biol Psychiatry, 2013,40(2) :273-280.
  • 4Cordeiro Q, Vallada H. Association study between the Taq1 A (rs1800497) polymorphism and schizophrenia in a Brazilian sample [J]. Arq Neuropsiquiatr, 2014, 72 (8) :582-586.
  • 5Lawford B R, Young R, Noble E P, et al. The D2 dopa- mine receptor (DRD2) gene is associated with comorbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder[J]. Eur Psy- chiatry, 2006,21 ( 1 ) :180-185.
  • 6Lubke G H, Hottenga J J, Waiters R, et al. Estimating the genetic variance of major depressive disorder due to all single nucleotide polymorphisms[ J]. Biol Psychiatry, 2012,72(8) :707-709.
  • 7Doehring A, Kirchhof A, Lotsch J. Genetic diagnostics of functional variants of the human dopamine D2 receptor gene [ J ]. Psychiatr Genet, 2009,19 ( 2 ) :259-268.
  • 8Lancaster S L, Rodriguez B F, Weston R. Path analytic examination of a cognitive model of PTSD Behaviour[ J ]. Behav Res Ther, 2011,49(2) : 94-201.
  • 9Inglis F M, Moghaddam B. Dopaminergic innervation of the amygdale is highly responsive to stress [ J ]. J Neuro- chem, 1999,72 ( 3 ) : 1088-1094.
  • 10Kunii Y, Miura I, Matsumoto J, et al. Elevated postmor- tem striatal t-DARPP expression in schizophrenia and as- sociations with DRD2/ANKK1 polymorphism [ J ]. Prog Neuropsychopharmacol Biol Psychiatry, 2014, 53 ( 1 ) : 123-128.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部